Russ Altman (Stanford University) & Kim Branson (GSK) - Principled Engineering: AI and Drug Development


Manage episode 322322476 series 2507147
Stworzone przez STVP and Stanford eCorner, odkryte przez Player FM i naszą społeczność - prawa autorskie są własnością wydawcy, a nie Player FM, a dzwięk jest przesyłany bezpośrednio z ich serwerów. Naciśnij przycisk Subskrybuj, aby śledzić aktualizacje Player FM, lub wklej adres URL kanału do innych aplikacji podcastowych.

Russ Altman is the Kenneth Fong Professor of Bioengineering, Genetics, Medicine, Biomedical Data Science and (by courtesy) Computer Science at Stanford University. His primary research interests are in the application of computing to problems relevant to medicine. Kim Branson is a senior vice president and Global Head of Artificial Intelligence and Machine Learning at GSK, where he leads the team, a group of nearly 100 machine learning researchers and engineers who are pioneering the application of AI to drug discovery and development. In this conversation with Stanford adjunct lecturer and STVP Director of Principled Entrepreneurship Jack Fuchs, Altman and Branson discuss how ethics and principles can shape innovation at the intersection of AI and drug development.


Stanford eCorner content is produced by the Stanford Technology Ventures Program. At STVP, we empower aspiring entrepreneurs to become global citizens who create and scale responsible innovations.







eCorner Website:

STVP Website:

Support our mission of providing students and educators around the world with free access to Stanford University's network of entrepreneurial thought leaders:

453 odcinków